Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcoma

Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcoma

Bibliographic Details
Main Authors:	Lamoureux, Francois, Baud'huin, Marc, Ory, Benjamin, Guiho, Romain, Zoubeidi, Amina, Gleave, Martin, Heymann, Dominique, Rédini, Françoise
Format:	Online
Language:	English
Published:	Impact Journals LLC 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202162/

Similar Items

Clusterin inhibition using OGX-011 synergistically enhances antitumour activity of sorafenib in a human renal cell carcinoma model
by: Kususda, Y, et al.
Published: (2012)

Molecular Alterations Associated with Osteosarcoma Development
by: Ando, Kosei, et al.
Published: (2012)

Farnesyl diphosphate synthase is involved in the resistance to zoledronic acid of osteosarcoma cells
by: Ory, B, et al.
Published: (2008)

Targeting the epigenetic readers in Ewing Sarcoma inhibits the oncogenic transcription factor EWS/Fli1
by: Jacques, Camille, et al.
Published: (2016)

OGX-427 inhibits tumor progression and enhances gemcitabine chemotherapy in pancreatic cancer
by: Baylot, V, et al.
Published: (2011)

Zoledronic acid inhibits pulmonary metastasis dissemination in a preclinical model of Ewing’s sarcoma via inhibition of cell migration
by: Odri, Guillaume, et al.
Published: (2014)

Current Therapeutic Strategies and Novel Approaches in Osteosarcoma
by: Ando, Kosei, et al.
Published: (2013)

Imatinib Mesylate Exerts Anti-Proliferative Effects on Osteosarcoma Cells and Inhibits the Tumour Growth in Immunocompetent Murine Models
by: Gobin, Bérengère, et al.
Published: (2014)

Clusterin facilitates stress-induced lipidation of LC3 and autophagosome biogenesis to enhance cancer cell survival
by: Zhang, Fan, et al.
Published: (2014)

Bone Tumor Environment as a Potential Therapeutic Target in Ewing Sarcoma
by: Redini, Françoise, et al.
Published: (2015)

99mTc-NTP 15-5 assessment of the early therapeutic response of chondrosarcoma to zoledronic acid in the Swarm rat orthotopic model
by: Miot-Noirault, Elisabeth, et al.
Published: (2013)

Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases
by: Lamora, Audrey, et al.
Published: (2015)

Zoledronic acid inhibits vasculogenic mimicry in murine osteosarcoma cell line in vitro
by: Fu, Dehao, et al.
Published: (2011)

Zoledronate‐Associated Osteonecrosis of the Jaw in a Dog with Appendicular Osteosarcoma
by: Lundberg, A.P., et al.
Published: (2016)

Downregulation of CXCR4 Expression and Functionality After Zoledronate Exposure in Canine Osteosarcoma
by: Byrum, M.L., et al.
Published: (2016)

Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis
by: Tellez-Gabriel, Marta, et al.
Published: (2016)

In vitro synergistic cytoreductive effects of zoledronic acid and radiation on breast cancer cells
by: Ural, A Ugur, et al.
Published: (2006)

Immune evasion strategies of neuroendocrine-like Enzalutamide resistant prostate cancer
by: Bishop, Jennifer L, et al.
Published: (2013)

TGF-β Signaling in Bone Remodeling and Osteosarcoma Progression
by: Lamora, Audrey, et al.
Published: (2016)

Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosis
by: Al Nakouzi, Nader, et al.
Published: (2016)

Phenotypic and functional analysis of lymphocytes infiltrating osteolytic tumors: use as a possible therapeutic approach of osteosarcoma
by: Théoleyre, S, et al.
Published: (2005)

Identification of Synergistic, Clinically Achievable, Combination Therapies for Osteosarcoma
by: Yu, Diana, et al.
Published: (2015)

Proapoptotic role of nuclear clusterin in brain
by: Kim, Nayoung, et al.
Published: (2011)

Cooperative Stabilization of Transthyretin by Clusterin and Diflunisal
by: Greene, Michael J., et al.
Published: (2014)

Clusterin Seals the Ocular Surface Barrier in Mouse Dry Eye
by: Bauskar, Aditi, et al.
Published: (2015)

Osteoprotegerin inhibits bone resorption and prevents tumor development in a xenogenic model of Ewing's sarcoma by inhibiting RANKL
by: Picarda, Gaëlle, et al.
Published: (2013)

Reduction in serum clusterin is a potential therapeutic biomarker in patients with castration-resistant prostate cancer treated with custirsen
by: Blumenstein, Brent, et al.
Published: (2013)

O011: Reduction of resistance by sublingual administration of antimicrobials
by: Catry, B, et al.
Published: (2013)

P03-011 - Differential for granulomatosis with polyangiitis
by: Rawn, SM, et al.
Published: (2013)

P01-011 – Colchicine compliance and amyloidosis
by: Ozdogan, H, et al.
Published: (2013)

Clusterin is a potential molecular predictor for ovarian cancer patient's survival: targeting Clusterin improves response to paclitaxel
by: Hassan, Mohamed K, et al.
Published: (2011)

Hypoxia Inducible Factor-1α Directly Regulates Nuclear Clusterin Transcription by Interacting with Hypoxia Response Elements in the Clusterin Promoter
by: Park, Jeongsook, et al.
Published: (2014)

Inhibition of the HER2-YB1-AR axis with Lapatinib synergistically enhances Enzalutamide anti-tumor efficacy in castration resistant prostate cancer
by: Shiota, Masaki, et al.
Published: (2015)

Isolation of circulating tumor cells in a preclinical model of osteosarcoma: Effect of chemotherapy
by: Antoine Chalopin, et al.
Published: (2018-09-01)

Zoledronic acid in metastatic osteosarcoma: encouraging progression free survival in four consecutive patients
by: Conry, Robert M., et al.
Published: (2016)

Relationship of clusterin with renal inflammation and fibrosis after the recovery phase of ischemia-reperfusion injury
by: Guo, Jia, et al.
Published: (2016)

Clusterin confers gmcitabine resistance in pancreatic cancer
by: Chen, Qingfeng, et al.
Published: (2011)

Genetics of Clusterin Isoform Expression and Alzheimer's Disease Risk
by: Ling, I-Fang, et al.
Published: (2012)

Clinical significance of clusterin expression in pancreatic adenocarcinoma
by: Jin, Junshuo, et al.
Published: (2012)

Correction: Clusterin confers gemcitabine resistance in pancreatic cancer
by: Chen, Qingfeng, et al.
Published: (2013)